Dr. Gabriel Alizaidy, MD, MS, is a physician-scientist specializing in hormone optimization, regenerative medicine, endocrinology, and longevity-focused therapeutic development. His work spans clinical research, product development, and translational science, with deep expertise in peptide therapeutics, cellular health, and metabolic optimization.
Dr. Alizaidy has worked extensively with advanced delivery systems and emerging nanotechnology applications, translating innovations in biotechnology into clinical frameworks used in regenerative and longevity medicine.
As a member of the Anera Scientific Advisory Board, he contributes his expertise in clinical research, peptide science, and therapeutic innovation, helping support the continued development of advanced longevity protocols.
Statement from Dr. Andrew J.M. Willoughby
President & Chief Science Officer
Gabriel will be a welcomed addition to our Scientific Advisory Board. His expertise in regenerative and longevity medicine, along with his understanding of endocrinology, peptide optimization, research and development, product development, and nanotechnology, aligns closely with my own philosophies and those of our advisory board members.
Welcome on board, Gabriel.
Statement from Dr. Gabriel Alizaidy
It is a pleasure to be working with Truc, Dr. Andrew J.M. Willoughby, and their Scientific Advisory Board. The concept of hyper-dense longevity supplements and advanced protocols developed by the Anera team is both highly distinctive and well-developed.
The science behind their nanotechnology platform, particularly its applications as an alternative peptide diluent and its potential role in addressing oral and gut dysbiosis, is intriguing. A healthy gut is foundational. When that system is intact, the downstream effects on immunity, cognition, metabolic function, and overall health are profound.
The level of research and scientific development behind Anera’s supplements, along with their integration into Mito-Epigenetic Optimization Protocols (MEOPs) and peptide product lines, is impressive. I look forward to contributing to the continued advancement of these technologies and protocols.
— Dr. Gabriel Alizaidy, MD, MS
To learn more about our mission, science, and NMN products, visit AneraLife.com
